Dexter Shurney, MD, MBA, MPH, chief health equity, diversity, and inclusion officer and chief medical officer at Adventist Health, explains the roles of health care systems and managed care organizations, and next steps to update policies, to ensure healthy food is available in all areas of the United States.
Dexter Shurney, MD, MBA, MPH, chief health equity, diversity, and inclusion officer and chief medical officer at Adventist Health, explains the roles of health care systems and managed care organizations, and next steps to update policies, to ensure healthy food is available in all areas of the United States. Shurney's talk, "Food As Medicine," was presented at the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum.
Transcript:
Residents in some areas of the United States live in food deserts and, on top of that, we have rising inflation. What role should managed care organizations and health care systems play here?
I think they can play a huge role. I mean, if they really are aware and understand the concept of food as medicine, they need to include that as part of their protocols when they treat patients. Now the problem is, oftentimes, it's not paid for. Medicare Advantage plans oftentimes have supplemental benefits that they can apply to such things, and they can ask for waivers and things like that, so you're starting to see some of that happen. I think more and more of that, we'll start to see.
There's been some great results. For example, Geisinger has just shown remarkable results in doing this for some of their patients. It's decreased their readmissions and things like that, so hopefully that will continue. I think there's a lot that managed care organizations can do, but we have to change some of the policies to fully get there.
What are the next steps for changing these policies?
There's plenty of research out there that shows the benefit of this. Where the research is probably not as strong as we would like, is that, oftentimes, it's been done by provider groups that don't have access to full claims data, so they haven't been able to fully show the ROI [return on investment].
We need to go to entities and do these kinds of studies with entities that have full access, not only just medical claims but also pharmaceutical claims and specialty pharmacy claims, as well. When you have that full data set then you can actually show the return on investment, so that's what we need. We know that we can move the numbers. I did a study when I was at Vanderbilt University about a decade ago and we really showed an ROI on this in 6 months because, using an anti-inflammatory diet, we were able to get people off of their high cost drugs, their specialty drugs. Even though you can't get everyone to eat healthy, you can't get everyone to adhere to medications either. But you can move the numbers, even if you move a few, particularly if you're dealing with specialty drugs.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More